{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:19:29Z","timestamp":1770823169758,"version":"3.50.1"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Levamisole is a known contaminant of cocaine and, via this route, has been associated with otherwise unexplained agranulocytosis. Levamisole is currently present in the majority of cocaine samples seized by the US Drug Enforcement Agency. We identified 20 cases of unexplained agranulocytosis in our practice locations of Albuquerque, NM, and Vancouver, Canada. Epidemiologic investigation revealed recent or ongoing cocaine use in 14 cases (70%). Certain morphologic features, including circulating plasmacytoid lymphocytes, increased bone marrow plasma cells, and mild megakaryocytic hyperplasia, were associated with the cocaine-exposed group. Of 5 patients tested, 3 (60%) were HLA-B27+ and showed antineutrophil antibodies, consistent with known associations of levamisole-induced agranulocytosis. One patient, who was positive for cocaine and levamisole by toxicology testing, died of infectious complications. Inadvertent consumption of levamisole via cocaine is a severely underappreciated risk factor for agranulocytosis, and specific laboratory features are suggestive of this etiology.<\/jats:p>","DOI":"10.1309\/ajcpopqnbp5thkp1","type":"journal-article","created":{"date-parts":[[2010,2,12]],"date-time":"2010-02-12T21:03:15Z","timestamp":1266008595000},"page":"466-472","source":"Crossref","is-referenced-by-count":87,"title":["Clinicopathologic Features of Agranulocytosis in the Setting of Levamisole-Tainted Cocaine"],"prefix":"10.1093","volume":"133","author":[{"given":"David R.","family":"Czuchlewski","sequence":"first","affiliation":[{"name":"1Department of Pathology, University of New Mexico Health Sciences Center, Albuquerque"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Brackney","sequence":"additional","affiliation":[{"name":"2New Mexico Department of Health, Santa Fe, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Ewers","sequence":"additional","affiliation":[{"name":"2New Mexico Department of Health, Santa Fe, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonaki","family":"Manna","sequence":"additional","affiliation":[{"name":"3Vancouver Island Health Authority, Vancouver, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Houman","family":"Fekrazad","sequence":"additional","affiliation":[{"name":"4Division of Hematology\/Oncology, University of New Mexico Health Sciences Center, Albuquerque"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afton","family":"Martinez","sequence":"additional","affiliation":[{"name":"2New Mexico Department of Health, Santa Fe, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kurt B.","family":"Nolte","sequence":"additional","affiliation":[{"name":"1Department of Pathology, University of New Mexico Health Sciences Center, Albuquerque"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Hjelle","sequence":"additional","affiliation":[{"name":"1Department of Pathology, University of New Mexico Health Sciences Center, Albuquerque"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Rabinowitz","sequence":"additional","affiliation":[{"name":"4Division of Hematology\/Oncology, University of New Mexico Health Sciences Center, Albuquerque"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian R.","family":"Curtis","sequence":"additional","affiliation":[{"name":"5Blood Center of Wisconsin, Milwaukee"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janice G.","family":"McFarland","sequence":"additional","affiliation":[{"name":"5Blood Center of Wisconsin, Milwaukee"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Baumbach","sequence":"additional","affiliation":[{"name":"2New Mexico Department of Health, Santa Fe, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn","family":"Foucar","sequence":"additional","affiliation":[{"name":"1Department of Pathology, University of New Mexico Health Sciences Center, Albuquerque"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2010,3,1]]},"reference":[{"key":"2023011906251272800_b1-1330466","first-page":"429","article-title":"Levamisole and agranulocytosis","volume":"24","author":"Kaplan","year":"1979","journal-title":"Cutis"},{"key":"2023011906251272800_b2-1330466","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/0192-0561(92)90179-O","article-title":"Levamisole, the story and the lessons","volume":"14","author":"Amery","year":"1992","journal-title":"Int J Immunopharmacol"},{"issue":"suppl","key":"2023011906251272800_b3-1330466","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1007\/s002800051084","article-title":"National Cancer Institute Clinical Trials Program in Colorectal Cancer","volume":"42","author":"Conley","year":"1998","journal-title":"Cancer Chemother Pharmacol"},{"key":"2023011906251272800_b4-1330466","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1080\/02841860902755244","article-title":"Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group","volume":"48","author":"Dahl","year":"2009","journal-title":"Acta Oncol"},{"key":"2023011906251272800_b5-1330466","first-page":"398","article-title":"Husbandry management, worm control practices and gastro-intestinal parasite infections of sows in pig-breeding farms in M\u00fcnsterland, Germany","volume":"111","author":"Gerwert","year":"2004","journal-title":"Dtsch Tierarztl Wochenschr"},{"key":"2023011906251272800_b6-1330466","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.2460\/javma.233.12.1913","article-title":"Prevalence of anthelmintic resistance on sheep and goat farms in the southeastern United States","volume":"233","author":"Howell","year":"2008","journal-title":"J Am Vet Med Assoc"},{"key":"2023011906251272800_b7-1330466","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0140-6736(77)91227-2","article-title":"Levamisole and agranulocytosis [letter]","volume":"1","author":"Rosenthal","year":"1977","journal-title":"Lancet"},{"key":"2023011906251272800_b8-1330466","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0192-0561(83)90065-6","article-title":"The dosage regimen of levamisole in cancer: is it related to efficacy and safety?","volume":"5","author":"Amery","year":"1983","journal-title":"Int J Immunopharmacol"},{"key":"2023011906251272800_b9-1330466","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0140-6736(78)91531-3","article-title":"High frequency of agranulocytosis in breast-cancer patients treated with levamisole [letter]","volume":"2","author":"Teerenhovi","year":"1978","journal-title":"Lancet"},{"key":"2023011906251272800_b10-1330466","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.forsciint.2007.05.021","article-title":"Unusual adulterants in cocaine seized on Italian clandestine market [letter]","volume":"172","author":"Fucci","year":"2007","journal-title":"Forensic Sci Int"},{"key":"2023011906251272800_b11-1330466","first-page":"134","article-title":"Levamisole: an analytical profile","volume-title":"Microgram J","author":"Valentino","year":"2005"},{"key":"2023011906251272800_b12-1330466","article-title":"Identification of levamisole impurities found in illicit cocaine exhibits","volume-title":"Microgram J","author":"Casale","year":"2008"},{"key":"2023011906251272800_b13-1330466","doi-asserted-by":"crossref","first-page":"287","DOI":"10.7326\/0003-4819-150-4-200902170-00102","article-title":"Agranulocytosis after consumption of cocaine adulterated with levamisole","volume":"150","author":"Zhu","year":"2009","journal-title":"Ann Intern Med"},{"key":"2023011906251272800_b14-1330466","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/j.1537-2995.2004.03410.x","article-title":"Neonatal neutropenia and bacterial sepsis associated with placental transfer of maternal neutrophil-specific autoantibodies","volume":"44","author":"Davoren","year":"2004","journal-title":"Transfusion"},{"key":"2023011906251272800_b15-1330466","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/j.1537-2995.2005.00199.x","article-title":"Neonatal alloimmune neutropenia attributed to maternal immunoglobulin G antibodies against the neutrophil alloantigen HNA-1c (SH): a report of five cases","volume":"45","author":"Curtis","year":"2005","journal-title":"Transfusion"},{"key":"2023011906251272800_b16-1330466","first-page":"1721","article-title":"Adverse reactions to levamisole","volume":"62","author":"Symoens","year":"1978","journal-title":"Cancer Treat Rep"},{"key":"2023011906251272800_b17-1330466","first-page":"436","article-title":"Granulocytotoxic autoantibodies in HLA-B27 neutropenic patients","volume":"27","author":"Drew","year":"1979","journal-title":"Transplantation"},{"key":"2023011906251272800_b18-1330466","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/ACI.0b013e3282370c5f","article-title":"Human leukocyte antigens and drug hypersensitivity","volume":"7","author":"Chung","year":"2007","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"2023011906251272800_b19-1330466","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1136\/ard.39.1.59","article-title":"Levamisole-associated neutropenia and autoimmune granulocytotoxins","volume":"39","author":"Drew","year":"1980","journal-title":"Ann Rheum Dis"},{"key":"2023011906251272800_b20-1330466","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/BF01727486","article-title":"Granulocytotoxic antibodies in levamisole-induced agranulocytosis [in German]","volume":"60","author":"Rosenthal","year":"1982","journal-title":"Klin Wochenschr"},{"key":"2023011906251272800_b21-1330466","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0140-6736(77)91119-9","article-title":"Recurrent agranulocytosis after levamisole [letter]","volume":"1","author":"Vanholder","year":"1977","journal-title":"Lancet"},{"key":"2023011906251272800_b22-1330466","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/ajh.2830090205","article-title":"Mechanisms of levamisole-induced granulocytopenia in breast cancer patients","volume":"9","author":"Vogel","year":"1980","journal-title":"Am J Hematol"},{"key":"2023011906251272800_b23-1330466","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1182\/blood.V56.3.388.388","article-title":"Studies on levamisole-induced agranulocytosis","volume":"56","author":"Thompson","year":"1980","journal-title":"Blood"},{"key":"2023011906251272800_b24-1330466","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1002\/art.23469","article-title":"Functional characterization of antineutrophil cytoplasmic antibodies in patients with cocaine-induced midline destructive lesions","volume":"58","author":"Peikert","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2023011906251272800_b25-1330466","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/bdd.2510070110","article-title":"Novel assay and pharmacokinetics of levamisole and p-hydroxylevamisole in human plasma and urine","volume":"7","author":"Kouassi","year":"1986","journal-title":"Biopharm Drug Dispos"}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/133\/3\/466\/48763303\/ajcp_133_3_466.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/133\/3\/466\/48763303\/ajcp_133_3_466.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T06:26:11Z","timestamp":1674109571000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article\/133\/3\/466\/1766434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,1]]},"references-count":25,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2010,3,1]]},"published-print":{"date-parts":[[2010,3,1]]}},"URL":"https:\/\/doi.org\/10.1309\/ajcpopqnbp5thkp1","relation":{},"ISSN":["1943-7722","0002-9173"],"issn-type":[{"value":"1943-7722","type":"electronic"},{"value":"0002-9173","type":"print"}],"subject":[],"published-other":{"date-parts":[[2010,3,1]]},"published":{"date-parts":[[2010,3,1]]}}}